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Abstract
Background: The in vitro generation of neurons from embryonic stem (ES) cells is a promising approach to produce cells
suitable for neural tissue repair and cell-based replacement therapies of the nervous system. Available methods to promote
ES cell differentiation towards neural lineages attempt to replicate, in different ways, the multistep process of embryonic
neural development. However, to achieve this aim in an efficient and reproducible way, a better knowledge of the cellular
and molecular events that are involved in the process, from the initial specification of neuroepithelial progenitors to their
terminal differentiation into neurons and glial cells, is required.
Methodology/Principal Findings: In this work, we characterize the main stages and transitions that occur when ES cells are
driven into a neural fate, using an adherent monolayer culture system. We established improved conditions to routinely
produce highly homogeneous cultures of neuroepithelial progenitors, which organize into neural tube-like rosettes when
they acquire competence for neuronal production. Within rosettes, neuroepithelial progenitors display morphological and
functional characteristics of their embryonic counterparts, namely, apico-basal polarity, active Notch signalling, and proper
timing of production of neurons and glia. In order to characterize the global gene activity correlated with each particular
stage of neural development, the full transcriptome of different cell populations that arise during the in vitro differentiation
protocol was determined by microarray analysis. By using embryo-oriented criteria to cluster the differentially expressed
genes, we define five gene expression signatures that correlate with successive stages in the path from ES cells to neurons.
These include a gene signature for a primitive ectoderm-like stage that appears after ES cells enter differentiation, and three
gene signatures for subsequent stages of neural progenitor development, from an early stage that follows neural induction
to a final stage preceding terminal differentiation.
Conclusions/Significance: Overall, our work confirms and extends the cellular and molecular parallels between monolayer
ES cell neural differentiation and embryonic neural development, revealing in addition novel aspects of the genetic network
underlying the multistep process that leads from uncommitted cells to differentiated neurons.
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Introduction
Neural induction in vertebrate embryos was first described by
Mangold and Spemann in 1924 [1] and results in the
establishment of a neuroectodermal primordium from where the
nervous system will arise. The molecular signals involved in this
crucial event are not yet totally elucidated but it is known that FGF
and WNT signalling are required, together with inhibition of BMP
signalling activity [2,3]. In the mouse embryo, the initial
population of specified neuroepithelial progenitors (NPs) is known
to express various pan-neural genes, like sox1 and sox2 [4,5]. These
NPs will then acquire competence to produce neurons when they
become part of the closing neural tube during neurulation, in a
process that involves retinoid signalling from adjacent somites and
the activity of proneural genes [6].
The embryonic neural tube is composed by a pseudostratified
layer of neuroepithelial cells with a clear apico-basal polarity. The
apical domain of these cells is located at the luminal surface and is
delineated by the presence of apical protein complexes, like the
PAR polarity complex [7], as well as by the presence of junctional
structures, where N-cadherin and b-catenin accumulate [8].
Centrosomes also localize apically in neuroepithelial cells, which
enter mitosis close to the luminal surface due to the characteristic
interkinetic nuclear movement (INM) [9]. This particular
organization of the neural tube is important for the coordinated
production of neurons and glia. Neighbouring neuroepithelial cells
signal to each other through Delta/Jagged ligands and Notch
receptors, in a process that maintains a population of proliferating
NPs and coordinates the timely production of neurons throughout
embryonic development (reviewed in [10,11]). This unique
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architecture of the embryonic neural tube has transient character
and disappears perinatally to give way to definitive CNS structures
like the brain and spinal cord.
Several approaches have been used to achieve in vitro neural
differentiation starting from embryonic stem (ES) cells, aimed at
generating regionally specified neural progenitors and/or differ-
entiated neuronal and glial subtypes. All these methods try to
recapitulate, in different ways, the multistep process of neural
development that occurs in the embryo, from neural induction to
the terminal differentiation of neurons and glial cells. This was
initially achieved through embryoid body (EB) formation in the
presence of retinoic acid [12] or, alternatively, by co-culture of ES
cells with stroma/conditioned medium [13,14]. However, as ES
cells are pluripotential and readily differentiate into almost any cell
type, the efficiency of neural conversion is limited and lineage
selection is usually needed to ensure homogeneity of the
differentiated population [15]. A simpler way to reconstitute
neural commitment in vitro and achieve efficient neuronal
production relies upon monolayer differentiation of ES cells, a
method developed by Ying and co-workers [16]. In this method,
ES cells are cultured in defined serum- and feeder-free conditions,
in the absence of BMP signals that are known to inhibit neural
fate. In these conditions, ES cells undergo neural commitment
through a ‘‘autocrine’’ induction mechanism, where FGF
signalling plays a pivotal role, as it does in the embryo [17,18].
This method results in a more efficient neural commitment and
differentiation, which likely results from a better mimicry of the
events that occur in the embryo. However, a detailed character-
ization of the cellular and molecular steps involved in promoting
ES cell differentiation towards neural lineages is required, not only
to enhance our understanding of neurodevelopmental mechanisms
but also to develop more rational ES cell-based strategies for
treating traumatic injuries and neurodegenerative diseases affect-
ing the human nervous system.
In this work, we describe various aspects of the process that
leads from ES cells to differentiated neurons in monolayer
cultures. Using improved conditions, we routinely obtain highly
homogeneous cultures of NPs that maintain morphological and
functional characteristics of their embryonic counterparts, namely
apico-basal polarity, active Notch signalling, and proper timing of
production of neurons and glia. We show that the transition to
neuronal production is accompanied by the organization of NPs
into neural tube-like rosettes, where these cells divide and give rise
to neurons. Furthermore, we have characterized the global gene
expression changes that occur along the path to neural
differentiation, from ES cells to neurogenic rosettes. Our results
confirm and extend at the molecular level the parallels with
embryonic neural development, revealing in addition novel aspects
of the genetic network underlying the multistep process that leads
from uncommitted cells to differentiated neurons.
Results
Improved generation of NPs from ES cells in defined
serum-free media
Commitment of undifferentiated ES cells to neural fate can be
achieved with high efficiency in feeder-free adherent monocul-
tures, using the serum-free medium N2B27 [16]. In these
conditions, when Sox1-GFP knock-in (46C) ES cells were used,
Ying and co-workers reported that cultures with more than 80% of
NPs (Sox1-GFP+) can be obtained [16]. Using the same ES cell
line, we carried out a comparative study of neural commitment in
N2B27 and RHB-A (StemCellSciences Inc., UK), a new N2B27-
based neural differentiation medium. We monitored cellular
growth, the emergence of Sox1-GFP+ NPs and the appearance
of various cell-specific markers in these cultures. Our results show
that commitment to neural fate in RHB-A occurs faster and
produces a higher percentage of Sox1-GFP+ NPs, when compared
to N2B27 (Fig. 1A). For instance, three days after ES cell plating in
RHB-A, more than 60% of cultured cells are Sox1-GFP+ NPs,
while only about 40% of cells became Sox1-GFP+ in N2B27 (p-
value = 0.005). The percentage of Sox1-GFP+ NPs in the total
population reaches a peak at day 4 in both media, with
consistently higher levels in RHB-A (p-value = 0.052). Further
culturing for 2 more days results in a sharp increase in the total
number of cells (Fig. 1B), but without changes in the percentage of
Sox1-GFP+ NPs (Fig. 1A). This suggests that, from day 4 onwards,
a ‘‘transit-amplifying’’ population of Sox1-GFP+ NPs is established
and that induction of new NPs contributes little to the growth of
this population.
RT-PCR analysis confirms that the switch from ES identity
(Oct4+, nanog+, sox2+, sox12, sox32) to that of NPs (sox1+,2+,3+,
blbp+,Oct42 and nanog2) seems to be complete by day 4 (Fig. 1C).
Before this, cells pass initially through a primitive ectoderm (PE)
stage, as shown by the expression of Fgf5 [19,20], preceding the
appearance of NP markers at day 3. In contrast, markers for
endodermal (hnf4, gata1) and epidermal (ker14) lineages are rapidly
down-regulated during monolayer differentiation (Fig. 1C).
Based on these results, we chose to replate day 4 NPs onto a
laminin substrate in the same RHB-A medium, to test their neural
differentiation potential. The cultures were maintained until day
20, being replated every 4th day. In these conditions, cell viability
remains high (above 90%), although the proliferation rate (shown
as fold increase–FI) decreases along time (Fig. 1D). The percentage
of Sox1-GFP+ NPs in culture also decreases, stabilizing above 70%
around day 8 (Fig. 1E).
NPs show proper apico-basal polarity in vitro and
undergo INM
After replating, we observed that cells grow in tightly packed
monolayers resembling thick epithelial sheets. However, the
distribution of Sox1-GFP+ cells is not uniform in these sheets,
being organized in clusters to form rosette-like structures (Fig. 1F).
In these clusters, Sox1-GFP+ NPs express the known apical
markers of neuroepithelial cells, N-cadherin and ZO-1, which are
localized at the centre of rosettes (Fig. 1F,G). This suggests that
NPs within these structures are organized with their apical
domains coalescing to form a central lumen, like in the embryonic
neural tube (Fig. 1H). This organisation is confirmed by the co-
localization of other known neuroepithelial apical markers at the
centre of rosettes, like PAR3 (Fig. 1I,J), aPKC (Fig. 1K), b-catenin
(Fig. 1L), Numb, Afadin and Occludin (not shown). Furthermore,
centrosomes are located close to the central region of the rosettes
(Fig. 1M), where mitotic (ppH3+) nuclei are also detected (Fig. 1N).
In contrast, S-phase nuclei lie at the periphery of rosettes, as
shown by short pulses of BrdU labelling (Fig. 1N). This suggests
that the nuclei of NPs within rosettes reproduce the characteristic
INM shown by NPs in the embryonic neural tube [9]. To confirm
this, we carried out time-lapse imaging of ES cell-derived neural
rosettes in culture, revealing that NPs do indeed undergo nuclear
movements coupled with the cell cycle, like embryonic NPs (Movie
S1). Finally, newborn neurons (Tuj1+) localize outside or at the
periphery of rosettes (Fig. 1O), resembling also the embryonic
neural tube where neurons accumulate outside of the ventricular
proliferative zone. Together, these observations reveal that rosettes
are remarkably organized like embryonic neural tubes, with ES
cell-derived NPs linked by junctional structures at their apical
surface and engaged on neurogenesis. This led us to explore
Road Map to Neurogenesis
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Figure 1. ES-cell derived NPs culture analysis. A) Percentage of GFP+ cells in monolayer cultures grown for 6 days without replating in RHB-A
and N2B27 media (* p-value= 0.005; ** p-value= 0.052). B) Fold increase (FI) for monolayer cultures grown for 6 days in RHB-A and N2B27 media. C)
Semi-quantitative RT-PCR analysis for selected markers of pluripotency and lineage commitment in day 0–6 RHB-A cultures; mRNA from E10.5 mouse
embryos was used as positive control. D) FI (filled squares) and viability (open squares) for RHB-A cultures maintained for 20 days in culture and
replated every 4 days at the same initial cell density. E) Percentage of Sox1-GFP+ cells along 20 days in culture in RHB-A, with replating every 4 days. In
all graphs data are means6SEM from at least three independent experiments. F) After replating in laminin (day 5), Sox1-GFP+ cells organize in
rosettes, with N-Cadherin (in red) present at the centre of these cell clusters. G) ZO-1 accumulates in the cell processes that coalesce at the centre of
rosettes, like it does in the apical domain of NPs in the embryonic neural tube (H). I) Anti-PAR3 immunostaining reveals well-defined ‘‘apical’’ domains
at the centre of rosettes, where it co-localizes with ZO-1 (J). K) aPKC, another known apical marker is also present at the centre of rosettes and co-
localizes with N-Cadherin. L) Adherent junctions’ components, ß-catenin and N-Cadherin, co-localize at the central, apical region of rosettes. M) Anti-
c-tubulin staining (in green) shows ‘‘apically’’ localized centrosomes. N) Mitotic figures (ppH3) are localized centrally in rosettes while S-phase nuclei
(BrdU) are located at the periphery. O) Differentiating Tuj1+ neurons accumulate at the periphery of rosettes. Nuclei counterstained with DAPI (blue).
Scale bar: 50 mm.
doi:10.1371/journal.pone.0006286.g001
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whether rosette-like cultures may have other structural and
functional similarities with the embryonic neural tube.
Notch pathway is active in rosette cultures
In the embryonic neuroepithelium, the Notch pathway controls
the rate at which proliferating NPs commit to differentiation.
When Notch activity is inhibited, precocious neuronal differenti-
ation is usually observed (reviewed in [21]). To test whether Notch
signalling is involved in maintaining NPs in cultured neuroepi-
thelial rosettes, as it happens in the embryonic neuroepithelium,
we first analysed the expression of various genes known to mediate
Notch activity (Fig. 2). RT-PCR data show that Notch1, 2 and 3 are
expressed in monolayer cultures, together with various Delta-like
and Jagged genes, as well as hes genes known to be involved in
embryonic neural development (Fig. 2A). Analysis by in situ
hybridization (ISH) reveals that hes5, the main Notch target gene
in embryonic NPs [22], is broadly expressed in neuroepithelial
rosettes, while Dll1 and hes6, which are normally expressed in
newborn neurons [23,24], show a more scattered expression,
consistent with being transcribed in rosette cells singled out for
differentiation (Fig. 2B, left panels). To evaluate the functional role
of Notch signalling in rosette cultures, its activity was inhibited by
treatment with the c-secretase inhibitor LY411575 [25], resulting
in a strong reduction of hes5 expression and the concomitant
increase in Dll1 and hes6 expression (Fig. 2B, right panels). These
results confirm the efficacy of Notch inhibition and show that
rosette progenitors embark on neuronal differentiation in the
absence of Notch activity. Indeed, LY411575-treated cultures
reveal a significant increase both in Tuj1+ (Fig. 2C) and HuC/D+
(Fig. 2D) neurons, accompanied by striking morphological
changes: after 48 h of Notch inhibition, rosette structures
disappear and give way to large rounded ganglion-like clusters
made up by Tuj1+ and HuC/D+ differentiating neurons, with
extensive neurite outgrowths. Quantification of the number of
HuC/D+ differentiating neurons reveals that the neurogenic effect
due to Notch inhibition is more pronounced in day 8 cultures
(n = 3, p-value = 0.002), while day 16 cultures show no increase of
neuronal production (Fig. 2D). However, Notch receptors and
ligands are still expressed at day 16, albeit at lower levels, making it
unlikely that the lack of neurogenic effects is due to the absence of
some components of the pathway. An alternative explanation is
that, by day 16, NPs have lost most of their neurogenic potential
and have switched their competence to gliogenic, as it has been
previously described to happen during embryonic neural devel-
opment and in cultures of isolated cortical NPs [26,27].
NPs have both neurogenic and gliogenic potential in
vitro
To test whether NPs in rosette cultures undergo a temporal
switch from early, neuron-producing, to late, glia-producing
progenitors, we quantified the production of neurons and glia
throughout the monolayer differentiation protocol. We found that
the number of HuC/D+ neurons in rosette cultures increases up to
day 12 and starts to decrease by day 16 (Fig. 3A). On the contrary,
GFAP+ glial cells can only be detected from day 16 on, after the
third replating, albeit still in reduced numbers (Fig. 3A). We
reasoned that 4 days of culture after replating might not be
sufficient to allow for glial differentiation and appearance of GFAP
immunoreactivity. We therefore extended cultures for 3 additional
days without replating (days 8+3, 12+3 and 16+3). In these
conditions, we could detect scattered GFAP+ cells as early as day
8+3, although still in reduced numbers (no more than 3 cells per
coverslip, Fig. 3B,C), in striking contrast with the number of HuC/
D+ differentiating neurons generated at the same time (Fig. 3D). In
day 12+3 cultures, GFAP+ cells can be detected consistently
(Fig. 3E), though they still appear in much lower numbers than
HuC/D+ neurons (Fig. 3F). The maximum number of GFAP+
cells occurs at day 16+3 (Fig. 3G), in contrast to that of HuC/D+
cells which peak at day 8+3 (Fig. 3H). Together, these results
reveal that the neurogenic potential of rosette cultures decreases
with time, with GFAP+ glial cells appearing consistently after the
peak of neuronal production (Fig. 3B), indicating that a switch of
progenitor identity, from neurogenic to gliogenic, occurs in these
cultures.
Neural stem cells are present in monolayer cultures
It is known that both embryonic neural tissue and certain
regions of the adult vertebrate CNS contain a resident population
of progenitor/stem cells [28]. Recent work [29,30] established
conditions for the isolation and clonogenic in vitro propagation of
neural stem (NS) cells derived either from ES cells or from
embryonic and adult neural tissue. In the present work, using the
same experimental conditions, we were able to derive floating
aggregates of NS cells from all stages of the in vitro neuroepithelial
rosette cultures (days 4, 8, 12, 16 and 20) with similar efficiencies
(Fig. 4A,B). When these aggregates are plated en bloc onto laminin
substrate, without dissociation, cells migrate out and form
neuroepithelial rosettes where all cells are positive for the NS
cells markers Sox2 (Fig. 4C) and Nestin (not shown). After several
days of culture, these cells develop very long cellular projections
similar to those of radial glia (Fig. 4C and data not shown) and are
able to differentiate into the all three neural lineages (Fig. 4C), a
feature that fits well with the characteristics of NS cells. The
constant presence of these cells, both in less proliferative day 20
monolayer cultures as well as in younger day 4 cultures (Fig. 4B),
indicates that the floating aggregates are derived from a resident
stem cell population, present in neuroepithelial rosette cultures at
all time points studied. This, in turn, provides additional evidence
for the neuroepithelial identity of these cultures.
Transcriptional profiling of in vitro neural commitment
The results described above indicate that neuroepithelial rosette
cultures recapitulate several aspects of embryonic neural tube
development. In contrast to the scarcity and complexity of cells
from early stages of mammalian embryos, these cultures can
provide large and highly homogeneous populations of cells at
various stages of neural development, with the additional
advantage of obtaining homogeneous populations of Sox1-GFP+
NPs by FACS sorting. This creates a unique opportunity to
characterize the transcriptional programs active at various phases
of neural commitment and differentiation, from which it might be
possible to predict the molecular pathways regulating these
processes. With this purpose, global gene expression profiling
using Affymetrix microarrays (Mouse Genome 430 Version 2.0)
was performed at several stages of the monolayer rosette cultures:
day 0 (undifferentiated ES cells), day 1, day 3 and day 8. At day 1,
ES cells have entered differentiation and our aim was to obtain a
gene signature for a population of primitive ectoderm-like cells
that is likely to be present, as marked by the up-regulation of Fgf5
expression and down-regulation of nanog (Fig. S1). At day 3, a
sharp up-regulation of sox1 is detected by RT-PCR (Fig. 1C),
probably reflecting the emergence of an initial population of NPs
after neural induction. To characterize the transcriptional
program active in these early NPs, we chose to purify Sox1-
GFP+ cells at day 3 by FACS sorting, resulting in two sub-
populations according to the levels of GFP expression (GFP+ and
GFP++, Fig. 5A). Our prediction was that cells with lower levels of
GFP might be at an earlier stage of NP development and that, by
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Figure 2. Chemical inhibition of the Notch activity by c-secretase inhibitor LY411575. A) Expression of Notch pathway genes during
monolayer ES cell differentiation, from day 0 to day 20, by RT-PCR analysis. mRNA from E10.5 mouse embryos was used as control. B) Detection by
ISH of Dll1, hes5 and hes6 transcripts in control (DMSO-treated) and LY411575-treated rosette cultures. Treatment was done in day 6 cultures for
24 hours. Nuclei counterstained with DAPI. C) After 48 h of LY411575 treatment, starting at day 6, massive neuronal differentiation is observed by
Tuj1 immunostaining. D) Notch inhibition with LY411575 at day 8 or 12 of the monolayer protocol results in increased neuronal production, detected
by HuC/D imunostaining. No change was detected when inhibition was done in day 16 rosettes. Bars in D represent SEM for the minimum of three
independent experiments. * p-value= 0.025; ** p-value= 0.002. Scale bars in B,C: 50 mm.
doi:10.1371/journal.pone.0006286.g002
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separating the two sub-populations of NPs, one could pull out
genes associated with the earliest NPs state. Finally, at day 8, NPs
are organized in rosettes and already engaged on neurogenesis, in
a stage likely to be equivalent to NPs from the embryonic neural
tube, after the onset of neuronal differentiation [55].
At least three independent RNA preparations from each of the
selected time points were processed and hybridized on the arrays.
Previous validation of these samples was done by analyzing the
expression of Oct4, nanog, hes5 and blbp by semi-quantitative RT-
PCR (Fig. 5B). As expected, expression of ES cell genes, Oct4 and
nanog, decrease throughout the differentiation process and are no
longer detected on day 3. In contrast, expression of NP markers,
hes5 and blbp, can only be detected at day 3, increasing significantly
at day 8. This pattern of expression was also observed in the
microarray profiling (Fig. 5C).
The microarray data were normalized by the log scale robust
multi-array analysis [31] and an ANOVA FDR-value of 1023 (p-
value,2.1024) was used to identify and restrict the number of
differentially expressed probe sets to 9456 (Table S1), which
correspond to 6563 unique genes. Further analysis of the
differentially expressed genes involved their distribution into
specific groups, according to the variations in their expression
throughout differentiation (Fig. 6 and Table S1). A first group was
defined as including genes whose expression peaks at day 0 and is
downregulated at all other time points. This includes known
pluripotency genes like nanog, rex1 and fbxo15, confirming the ES
cell identity of the initial population at day 0. A second group
includes genes with a peak of expression at day 1 and might
identify a transient PE population as indicated by the presence of
Fgf5 in this group [19,20]. A third group includes genes that are
Figure 3. Timing of production of neurons and glia in rosette cultures. A) Percentage of HuC/D+ and GFAP+ cells in rosette cultures, relative
to the total number of cells in culture. A decrease in neuronal production is observed at day 16, concomitant with an increase of glial cells. B) Semi-
quantitative RT-PCR data showing fold change of expression (relative to day 0) for neuronal (tau) and glial (gfap) markers at successive timepoints of
rosette cultures. Data normalized to gapdh. C–H) Rosette cultures at day 8+3, 12+3 and 16+3, labelled with anti-HuC/D and anti-GFAP antibodies to
visualize neurons and glial cells, respectively. Few GFAP+ cells appear in day 8+3 cultures (C), with the number increasing at day 12+3 (E) and 16+3 (G).
In contrast, a decrease in the number of HuC/D+ neurons is detected at day 16+3 (H). Nuclei counterstained with DAPI (blue). Scale bars: 50 mm.
doi:10.1371/journal.pone.0006286.g003
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up-regulated at day 3 but down-regulated in day 8 rosettes, and
might characterize a transient population of Sox1-GFP+ NPs
(tNPs) that emerge after neural induction. These progenitors will
then evolve into neurogenic progenitors (nNPs) competent to
initiate neuronal production, identified by a fourth group
containing genes that start to be up-regulated at day 3 but
continue to be expressed at similar or higher levels in day 8
rosettes. Finally, a fifth group is composed by genes that are only
up-regulated in day 8 rosettes and includes genes characteristic of
progenitors in the final phase of commitment to differentiation,
like the proneural genes ascl1, neuroG1 and neuroG2 [32], as well as
genes known to be expressed in early differentiating neurons, like
doublecortin and hu/elav [33,34].
This distribution of transcriptional profiles depicts, at the
molecular level, the successive cellular states that occur along the
path to neural differentiation, allowing the identification of gene
signatures for each of these states and a better definition of the
transitions between them.
Discussion
In this work, we characterize at the cellular and molecular level the
processes of neural commitment and differentiation that occur when
mouse ES cells are driven into a neural fate, using an improved
adherent monolayer protocol [16,35]. We show that NPs derived
from ES cells organize themselves into rosette-like structures, with an
apico-basal distribution of polarity proteins similar to that described
for neuroepithelial cells in the embryonic neural tube [7,8]. In
addition, ES cell-derived rosette NPs display the characteristic cell
cycle-related INM of the embryonic neuroepithelium. We also show
that Notch signalling is active in neuroepithelial rosettes and controls
the timely production of neurons from ES cell-derived NPs. The
intrinsically controlled sequential generation of neurons and glial cells
seems to be also preserved in ES cell-derived NPs. Altogether, these
results demonstrate that the in vitro generation of neural cells from ES
cells, using the monolayer protocol, closely mimics the process of
embryonic neural development. Global gene expression analysis, at
successive steps of the process that leads ES cells to neurons, provides
further support for the similarities between the ES cell-derived rosette
culture system and embryonic neural tube development, revealing in
addition novel candidate genes that might regulate the processes of
neural commitment and differentiation.
Neuroepithelial rosettes as in vitro counterparts of
embryonic neural tube
Several methods have been described to achieve neural
differentiation of ES cells in vitro (reviewed in [36,37]), including
the treatment of cell aggregates (EBs) with retinoic acid [12] or the
co-culture of ES cells with stromal cells that produce uncharacter-
ized neural-inducing factors [14]. The concept of neural induction
as a default pathway for differentiation in early vertebrate embryos
[2] led to the development of a simple adherent monolayer culture
system where ES cells are driven by autocrine signalling into a
neural fate, using a defined serum-free media (N2B27). In these
conditions, endogenous FGF and Notch signalling seem necessary
Figure 4. NS cell potential of the in vitro neuroepithelial rosette cultures. A) Floating aggregates of NS cells derived from day 4 monolayer
cultures (Sox1-GFP 46C cells; phase contrast and GFP fluorescence images). B) Efficiency of derivation of NS cells-derived floating aggregates from
several rosette cultures time points (days 4, 8, 12, 16 and 20), expressed as number of aggregates formed per 1000 cells. Bars represent SEM for 3
independent experiments. C) Floating aggregates of NS cells (derived from day 4 monolayer cultures of 46C) were left to attach for 4 days onto
laminin substrate and stained for Sox2 (NP marker), Doublecortin (DCX, neuronal marker), GFAP (glia) and O4 (oligodendrocytes). Scale bars: 50 mm.
doi:10.1371/journal.pone.0006286.g004
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for ES cells to enter the neural pathway [17,18,38], together with
the production of endogenous inhibitors of BMP signalling [16].
Using this monolayer protocol, one can routinely obtain an
enriched population of NPs (up to 80%) after 4–6 days in culture,
although the presence of ‘‘contaminating’’ cells (undifferentiated ES
cells and large flatten non-neural differentiating cells) is still
observed, probably due to some remaining endogenous BMP
signalling. In this work, we report that the use of a new N2B27-
derived medium (RHB-A) allows a faster and more efficient
production of NPs from ES cells in monolayer culture (Fig. 1A),
resulting in highly homogeneous populations of NPs (up to 90%)
that can subsequently differentiate into neurons, astrocytes and
oligodendrocytes. The observation in the reduction of large flatten
non-neural cells in RHB-A cultures correlates with the observed
decrease of BMP4 expression (Fig. S2), along with an increase in the
expression of known BMP-antagonists (e.g. Chordin-like1, Follista-
tin), in contrast to what has been reported for N2B27 cultures [16].
The transition from ES cells to NPs in RHB-A monolayer
cultures is accompanied by the organization of these NPs into
characteristic rosette-like structures, in a process that resembles
neural tube formation in the embryo. The formation of similar
rosettes has been described in other in vitro models of neural
differentiation from ES cells [39,40], suggesting that this is a
common behaviour of NPs, associated with their epithelial
Figure 5. Validation of microarrays results. A) Histogram of sorted Sox1-GFP populations from day 3 monolayers. GFP negative (GFP-) cells were
discarded, while two GFP positive populations were collected individually, according to their levels of GFP expression (GFP+ and GFP++). B) RT-PCR
analysis of RNA samples collected for microarray analysis for the genes Oct4, nanog, hes5, and blbp. C) Fold changes, relative to day 0, obtained from
Affymetrix profiling for the genes Oct4, nanog, hes5, and blbp.
doi:10.1371/journal.pone.0006286.g005
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Figure 6. Clustering analysis of differentially expressed genes. A) Frequency distribution of the expression levels of the genes belonging to
the five defined groups. B) Dendogram of the relationship of expression of genes belonging to each group (with biological replicates being
represented by the letters A, B, C and D) and examples of genes that are present in the five defined groups. C) Schematic representation of the
successive cellular states that occur along the path to neural differentiation (see text for definitions of stages).
doi:10.1371/journal.pone.0006286.g006
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character. We have studied in detail the organization of these
rosettes and show that several proteins normally present in the
apical domain of embryonic neuroepithelial cells, like N-Cadherin,
ß-catenin, Par3/aPKC and Numb, are localized close to the
luminal centre of rosettes, revealing that ES cell-derived NPs are
able to acquire a proper apico-basal organization, despite being
cultured in a 2D environment. In addition, we show that NPs
within rosettes display the characteristic INM observed in the
embryonic neuroepithelium, with progenitors entering mitosis
when their nuclei are closer to the luminal surface of rosettes. We
also noted that differentiating neurons loose contact with the
centre of rosettes and migrate to their periphery. Altogether, these
findings reveal that NPs in culture are able to self-organize into
neural tube-like structures, thus recapitulating the cellular
interactions that regulate the process of neuronal production.
Notch activity is a major player in this process (reviewed in
[11,21,41]) and the parallel between embryonic neurogenesis and in
vitro neural differentiation of ES cells is reinforced by the similar
dependence on Notch signalling to maintain a population of NPs
engaged on neuronal production. Indeed, we show that Notch
signalling is active in ES cell derived neuroepithelial rosettes and
that chemical inhibition of Notch activity results in massive
neuronal differentiation of rosette NPs, similarly to what has been
described during CNS embryonic development (reviewed in
[11,21]). Interestingly, this drift to neuronal differentiation in the
absence of Notch activity is no longer seen on day 16 cultures,
suggesting that neuronal competence decreases with time. This is
confirmed by the striking reduction in the number of neurons
generated in later cultures, concomitant with an increase in the
generation of GFAP+ glial cells, revealing a switch from neurogenic
to gliogenic NPs in late monolayer cultures. This switch coincides
with the disappearance of rosettes from the cultures: while ES cell-
derived NPs grow exclusively in the form of rosettes up to day 12,
few rosettes are still present at day 16 as neuronal production is
significantly decreased and gliogenesis increases. These observations
indicate that the intrinsic temporal regulation of neurogenic vs.
gliogenic differentiation, characteristic of embryonic neural tube, is
conserved in ES cell-derived rosette cultures. How this temporal
regulation occurs in vitro is still unclear but must be independent of
extrinsic cues, as previously reported for embryonic NPs [26,27].
Altogether, our data extend the previous characterization of the
monolayer protocol as an efficient and reproducible method to
drive ES cells into a neural fate and provide further evidence that
the steps involved in the in vitro acquisition of a neural fate closely
mimic the events that happen during embryonic neural commit-
ment and differentiation.
Molecular mechanisms of in vitro mammalian neural
development
The path from ES cells to a neural fate involves various
transitions in the potential of the cells, starting with the conversion
to a PE-like stage followed by the transition into neuroectoderm
and establishment of a population of NPs that will gradually give
rise, first, to differentiated neurons and, later, to glial cells. To
characterize these cellular states at the molecular level and identify
genes that might promote the transitions between successive
stages, we have performed global transcriptome analysis of ES cells
and their derivatives along the path to a neural fate. This resulted
in the identification of a large set of genes (6.563) whose expression
significantly changes throughout the monolayer neural differenti-
ation protocol. Analysis of the data involved the clustering of these
genes into five groups according to their expression profiles, which
we correlated with diverse cell populations that emerge in the
course to neural differentiation.
The first group comprises genes with a peak of expression at day 0
and that are rapidly down-regulated as ES cells loose their ‘‘stemness’’
character. This group includes known pluripotency markers of the ES
cell state, like nanog, zfp42/rex1, fbxo15, tdgf1/cripto1, socs3, esrrb, klf4
and klf5, and provides an ES cell signature that overlaps extensively
with available data on ES cell specific transcripts [42,43,44]. Other
known ‘‘stemness’’ genes like Pou5f1/Oct4 and sox2 are also strongly
expressed in the starting population of ES cells but were excluded
from our first gene group as their expression reappears in NPs (sox2)
or takes longer to be down-regulated (Pou5f1/Oct4). Together, these
data confirm the ES cell identity of the starting population of cells and
could also serve to identify novel genes that might be important to
maintain the ES cells status.
A second group includes the genes whose expression peaks at day
1 after ES cells have been plated in RHB-A, being subsequently
down-regulated in NPs and neural rosettes. This group includes the
PE marker Fgf5 and might represent a gene signature for the PE-like
stage that emerges after plating of ES cells in the absence of serum
and leukaemia inhibitory factor (LIF). Until now, this stage has been
characterized by the up-regulation of Fgf5 expression and
downregulation of zfp42/rex1, in a population still expressing Oct4
[19,45,46], a pattern that is also observed in our data. Although
epiblast stem cells (EpiSCs) reveal a similar expression profile
[47,59], the absence of markers of tripotency in our day 1 PE-like
cells (e.g. brachyury, otx2, gata4 and gata6), together with the down-
regulation of most ES cell genes (included in group I), implies that
this population is different from EpiSCs.
A survey of the 66 genes included in this PE-like group reveals
the presence of 5 genes involved in calcium homeostasis (calcR, ryr-
3, otopetrin1, tnnc2 and cyp24a1) suggesting that calcium signalling
plays an important role in the transition of pluripotent stem cells
into ectodermal fates. Indeed, an increase in intracellular calcium
has been reported to be important for neuralization of ectodermal
cells [48]; hence, the activity of the 5 identified genes might
contribute to regulate calcium signalling in PE-like cells transiting
to a neural fate. It would, therefore, be interesting to test whether
these genes, as well as other candidate PE markers present in this
group, are expressed in the mouse embryonic PE and what
function they have in this tissue.
A third group comprises genes that are up-regulated in NPs
(Sox1-GFP+) at day 3 but down-regulated in day 8 neurogenic
rosettes. This behaviour indicates that these genes might play a
role in the establishment of the initial population of NPs, but are
switched-off afterwards to allow the subsequent progression to
differentiation. In the embryo, a gene that shows a similar
behaviour is sox1, whose down-regulation in NPs seems to be
required for their commitment to differentiation, due to its ability
to block the neurogenesis-promoting activity of proneural factors
[5,49]. During ES cell differentiation, sox1 expression also peaks in
day 3 NPs but does not decrease enough in day 8 rosettes to be
included in this group, due to the stringent criteria that was
chosen. Still, this group contains various genes that are known to
be transiently expressed in embryonic NPs and regulate their
generation, like the BMP inhibitor chdl1, the Wnt modulator frzb1
and the orphan nuclear receptor nr6a1 [50,51,52], supporting the
analogies with embryonic neural development. Of the 61 genes
included in this group, 43 are known to be expressed in embryonic
NPs (by screening publicly available databases), while there is
incomplete or no available data on the expression of the remaining
18 genes. We therefore propose that this group provides a novel
gene expression signature for a transient population of NPs (tNPs)
that is established following neural induction but that it is not yet
competent to enter neurogenesis. This absence of neurogenic
competence correlates with the reduced expression of proneural
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genes in day 3 Sox1-GFP+ NPs and the lack of an increase in
Notch activity, as measured by the expression of Notch1 and its
targets and effectors hes5 and hes6 (Fig. S3).
This proposed tNP population is also likely to exist in the mouse
embryo but the small number and transient character of tNPs, together
with the ‘‘dilution’’ effect due to the presence of several other cell types,
has made difficult to pinpoint its existence. The genes we have
identified here as markers of the tNP population may now allow the
identification of similar progenitors in the mouse embryo and provide
an entry point to dissect the genetic circuitry controlling this stage of
neural development.
The fourth group comprises genes that are up-regulated in NPs but
that, in contrast to tNP genes, continue to be expressed at similar or
increased levels in day 8 neurogenic rosettes. Our strategy of separating
NP genes into two groups with distinct expression profiles highlights, on
one side, genes which are active only during progenitor specification
(tNP group) and, on the other side, genes that might also be important
for the next stage of NP development (nNP), when competence to enter
neurogenesis is acquired. By analogy with embryonic neural
development, nNPs are likely to be an in vitro counterpart of the
progenitors present in the ‘‘transition zone’’ or ‘‘pre-neural tube’’,
located at the caudal open neural plate, rostral to the node but
posterior to the level of the first somite [6,53]. Indeed, a survey of nNP
genes reveals that the transition to a proliferative neurogenic
population observed in monolayer cultures is accompanied by a
significant increase on the expression of genes connected to the retinoic
acid signalling (e.g., rxr-alpha, crabp2, nr2f1, nr2f2) and Wnt pathway
(e.g., fzd1, fzd3, sfrp2, tcf4, wnt5a, wnt8b, gsk3ß, lrp1), which are known to
regulate NP competence in vivo [54,55]. Together, our data provide an
accurate gene signature for two populations of NPs (tNPs and nNPs),
with a high degree of confidence that results from the fact that FACS-
purified populations of NPs were used in our experiments.
A population of purified Sox1-GFP+ NPs has previously been
studied in Sox1GFP transgenic mouse embryos with 15 genes being
found to be preferentially expressed in embryonic NPs [56]. Of these,
8 genes are also found in our nNP gene group (sfrp2, lrrn1, sox4, zic1,
vim, rtn1, sox11, qk), while 4 other genes (khdrbs3, msi2, hrmtl3, tuba1)
show similar expression profile (up-regulated at day 3 NPs and/or
day 8 rosettes) but were excluded due to the stringent criteria used to
generate the clusters. Concerning the other 3 genes, one is mainly
expressed in day 8 rosette NPs (nhlh2), another was not included in the
microarrays (Mm.156164) and slc2a1 is not differentially expressed
during ES cell differentiation. The fact that none of the tNP genes
were found in the embryonic Sox1-GFP+ population might be due to
the limited number of genes screened in the embryo (384 in total) and
to the expected transient character of tNPs in vivo, which might
preclude their isolation from whole mouse embryos at E10.5.
Nonetheless, this comparison reveals a strong correlation between the
data generated from in vitro neural differentiation of ES cells and the in
vivo data obtained from the developing mouse embryo, supporting
our proposal that the gene signatures defining NP developmental
stages in vitro might serve to identify similar stages during embryonic
nervous system development.
The fifth group comprises genes that are up-regulated in day 8
cultures, when NPs are organized in neural tube-like rosettes and
actively engaged in neurogenesis. Genes that were already up-
regulated in day 3 NPs and that are linked to the previous stages of
NP specification and proliferation (included in groups III and IV),
were excluded from group V. In this way, this group is enriched in
genes linked to the final stages of NP development and
commitment to neuronal differentiation, revealing a gene
expression profile in day 8 neural rosettes that matches the
transcriptional landscape of the embryonic neural tube. For
instance, proneural genes like neurog1, neurog2 and ascl1, which are
known to promote neuronal commitment, cell cycle exit and entry
into differentiation of embryonic NPs, are included in group V.
Additionally, genes encoding neuronal determination bHLH
proteins, like neurod4, nhlh1 and nhlh2, which are known to be
activated by the proneural genes and function in early post-mitotic
neurons to implement the neuronal differentiation program, are
also present in this group. The similarities between embryonic
neural tube and monolayer neural rosettes extend also to the
increased transcription of genes of the Notch pathway, which are
involved in regulating the balance between NP maintenance and
differentiation, both in neural rosettes and in the embryonic neural
tube. Other genes up-regulated in day 8 neural rosettes are known
to be linked to neuronal type specification, like lhx1, lhx9, islet1,
lmo2 and various members of the Brn/Pou family, or associated
with the general process of neuronal differentiation, like dcx, elav1,
2, 3 and 4, and neurexin. Altogether, this expression profile provides
additional evidence, at the molecular level, of the similarities
between the embryonic neural tube and the neural rosettes
obtained by monolayer differentiation of ES cells.
A recent study reported the characterization of neural rosettes
obtained by differentiating human ES cells through EBs or by co-
culture with stromal cells [39]. Exposure of these rosettes to
FGF2/EGF signalling resulted in the establishment of NS-like cells
similar to those we obtained from mouse neural rosettes with the
same growth factors. Gene expression profiling of these human ES
cell-derived neural rosettes revealed a group of genes with highly
increased expression in rosettes vs. human ES cells. Most of these
are also highly expressed in the neural rosettes obtained from
mouse ES cells described in this work (for instance, plagl1, dach1,
plzf/zbtb16, nr2f1, zic1, fabp7, lhx2, pou3f3), suggesting a conserved
general programme of NP/NSC development in mice and
humans. Although these genes are highly expressed in rosette
cells, our analysis reveals however that they are already up-
regulated at day 3 of monolayer culture, before rosette formation,
pointing to the existence of evolving populations of NPs/NSCs
that emerge at different times of neural development.
To better define these NP populations, we took advantage of the
simplicity of the monolayer method and the ability to purify Sox1-
GFP+ NPs before rosette formation, to produce an accurate gene
profiling dataset at various stages of in vitro neural development. By
using embryo-oriented criteria to cluster the differentially
expressed genes, our analysis did indeed allow us to pinpoint
successive stages in the development of NPs, identified by unique
gene signatures. A first signature defines a transient ‘‘tNP’’
population that emerges after neural induction and that gives rise
to a subsequent population of ‘‘nNPs’’ with a different gene
expression profile and already competent to enter neurogenesis.
This is a ‘‘transit-amplifying’’ population of NPs that give rise to a
final set of NPs organized in rosettes, expressing proneural genes
and committed to exit the cell cycle and enter terminal
differentiation. We propose that these stages also exist during
embryonic development and future work shall explore whether the
gene signatures here defined can serve to identify equivalent NP
populations in the mouse embryo.
Materials and Methods
Maintenance and differentiation of mouse ES cells
The ES cell lines used for this study were E14tg2a and two
derivatives, 46C (Sox1-GFP, [16]) and S25 (Sox2-bgeo, [15]), all
three a gift from Meng Li (MRC Clinical Sciences Centre, Faculty
of Medicine, Imperial College, London, UK) and Austin Smith
(Wellcome Trust Centre for Stem Cell Research, University of
Cambridge, Cambridge UK). ES cells were grown at 37uC in a
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5% (v/v) CO2 incubator in Glasgow Modified Eagles Medium
(GMEM, Invitrogen), supplemented with 10% (v/v) fetal bovine
serum (FBS) (ES-qualified, Invitrogen), 2 ng/ml LIF and 1 mM 2-
mercaptoethanol, on gelatin-coated (0.1% (v/v)) Nunc dishes.
Cells were passaged every other day, at constant plating density of
36104 cells/cm2. To start the monolayer protocol, ES cells were
plated in serum-free medium ESGRO Complete Clonal Grade
medium (Millipore Inc.) at high density (1.56105 cells/cm2). After
24 hours, ES cells were gently dissociated and plated onto 0.1%
(v/v) gelatin-coated tissue culture plastic at 16104 cells/cm2 in
RHB-A or N2B27 media (StemCell Science Inc.), changing media
every other day. For replating on day 4, cells were dissociated and
plated at 26104 cells/cm2 onto laminin-coated tissue culture
plastic in RHB-A medium supplemented with 5 ng/ml murine
bFGF (Peprotech). From this point on, cells were replated in the
same conditions every 4th day and the medium was changed every
2nd day, for the total of 20 days in culture. To quantify the number
of differentiating neurons at each time point, cells were plated onto
laminin-coated glass coverslips in 24-well Nunc plates and, 2 days
after plating, medium was changed to a RHB-A:Neurobasal:B27
mixture (1:1:0.02), to allow a better survival of differentiated
neurons. To obtain floating aggregates of NS cells, 36105 cells,
dissociated at day 4, 8, 12, 16 and 20 of culture, were plated onto
uncoated culture plastic in RHB-A medium supplemented with
10 ng/ml of recombinant murine EGF and bFGF (Peprotech)
[57]. Floating aggregates formed within 24 hours and medium was
changed after 48 h. After 4 days in suspension culture, aggregates
were counted and plated en bloc onto laminin-coated coverslips,
being then cultured for 4 days in RHB-A medium (with an
intermediate medium change) to allow differentiation. When
required, 10 mM BrdU (Sigma) was added to cultures for 5 min
immediately before fixation.
Treatment with c-secretase inhibitor LY411575
Treatment with LY411575 was done at day 6, 10 or 14 after the
beginning of the protocol. At these time points, culture medium
was substituted by RHB-A: Neurobasal: B27 (1:1:0.02) medium
supplemented either with 0.01% DMSO (control) or with 3 nM
LY411575 (in 0.01% DMSO). Cells were fixed in 4% (w/v)
paraformaldehyde after 24 h or 48 h of incubation, respectively,
for the ISH and for the immunostaining.
Immunocytochemistry
Fixed cells were blocked with 10% (v/v) FBS and 0.05% (v/v)
Tween in phosphate buffered saline (PBS) for 1 hour, followed by
incubation overnight with primary antibodies (Table S2). For all
double immunostainings (with the exception of those with anti-
GFP antibody), monolayer cultures of either S25 or E14tg2a ES
cells were used. 46C cells were used in double immunostainings
with anti-GFP antibody. Cells were washed 3 times in PBS
followed by incubation for 1–2 hours with AlexaFluor-conjugated
secondary antibodies (Molecular Probes) and DAPI (1:10000,
Sigma). For the detection of BrdU incorporation, cells were
treated with 2N HCl for 30 min at 37uC at the beginning of the
immunostaining procedure. Images of fixed cells were obtained
with a DM5000B microscope and a DC350F camera (Leica
Wetzlar, Germany). Living cells were photographed under an
inverted microscope Leica DMIL with a DC200 camera. Images
were processed by using Photoshop CS (Adobe, San Jose, CA).
The number of HuC/D and GFAP expressing cells was
quantified as a proportion of the total number of cells in culture,
counted with the help of ImageJ Cell Counter software. The
number of positively labelled cells was quantified by counting 10 to
20 randomly selected fields per coverslip, corresponding to a
minimum 5000 cells, counted as DAPI nuclei. Two coverslips were
counted per each condition and the analysis was repeated for at least
three independent experiments for each of S25 and 46C ES cell
lines. Student t-test was used to compare means between groups and
p-values lower than 0.05 were considered statistically significant.
In situ hybridization
Digoxygenin-labeled RNA probes for hes5, hes6 and Dll1 were
synthesized by T7 RNA polymerase from plasmid templates.
Whole-mount ISH procedure [24] was adapted to cultured cells
with minor modifications. After incubation with AP-conjugated
anti-Dig antibody (Roche Diagnostics) coverslips containing
cultured cells were incubated with AP substrate FastRed (Roche
Diagnostics) for 0.5–1 h at 37uC. Anti-GFP immunostaining was
performed after ISH when required.
FACS analysis
Cells were dissociated and resuspended in 4% (v/v) FBS in PBS.
Sox1-GFP analysis was performed on a FACS Calibur cytometer
(Becton Dickinson), and all cell sorting experiments were done on
a FACS Aria cell sorter (Becton Dickinson). Live cells were gated
based on forward scatter and side scatter and/or by propidium
iodide dye exclusion. For sorting, the GFP+ and GFP++ NPs
populations were collected (the GFP negative cell fraction was
discarded) and cell viability at the end of the FACS sorting
procedure was determined using trypan blue dye exclusion
method. FACS sorted cells were directly processed for RNA
extraction.
RNA extraction and RT-PCR
Total RNA was extracted from 106 cells using High Pure RNA
Isolation kit (Roche Diagnostics), with the inclusion of DNAseI
treatment according to manufacturer’s instructions. The first
strand cDNA was synthesized from 0.5 mg of total RNA using
SuperscriptII Reverse Transcriptase (Invitrogen) and random
hexamers. After synthesis, each cDNA was diluted 5-fold and 5 ml
of diluted cDNA used in PCR reaction with gene-specific primers
(Table S3). The absence of contaminating genomic DNA was
confirmed for each RNA extraction by PCR amplification of
GAPDH-specific product from RT negative samples. The relative
amount of each transcript was normalized to the level of GAPDH.
Time-lapse movie
Day 4 or day 8 rosette NPs were plated onto laminin-coated
MatTek dishes and rosettes were allowed to form for 24–48 h in a
conventional CO2 incubator. Cultures were imaged on an
inverted fluorescence Zeiss Axiovert 200M microscope in a
chamber kept at 38uC. The chamber stage was buffered with
5% CO2/95% air mix and maintained in a humid environment.
Images in bright field were captured using a 4060.75 NA objective
lens (Zeiss EC Plan-Neofluar) with the Hg-arc lamp and acquired
with Metamorph software (Molecular Devices). The culture was
permanently illuminated and seven focal points were imaged at
2 min intervals, for up to 16 hours. Data was analysed using
ImageJ software, by choosing the most focused plane, adjusting
brightness and contrast, and after instant time concatenation.
Microarray sample preparation and data analysis
Total RNA was extracted from day 0 undifferentiated cells, day
1 ectodermal cells, day 3 FACS-purified Sox1-GFP+ and Sox1-
GFP++ NPs, and day 8 neuroepithelial rosettes, using High Pure
RNA Isolation kit (Roche Diagnostics). The preparation quality
was assessed by agarose-formaldehyde gel electrophoresis. Three
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(or four in the case of 3++ samples) independent preparations (A to
D), each containing total RNA from the day 0 (0), day 1 (1) day 3
(3+ and 3++) and day 8 (8) of differentiation were processed at the
Max-Delbru¨ck-Centrum fu¨r Molekulare Medizin (Berlin, Ger-
many) according to the standardized procedures adopted by all
members of the FunGenES European Consortium (http://www.
fungenes.org/).
For the synthesis of double-stranded cDNA (from 15 mg of total
RNA) the cDNA synthesis system kit (Roche Diagnostics) was
used. Biotinylated cRNA were synthesized with Perkin-Elmer
nucleotide analogues using the Ambion MEGAScript T7 kit. After
fragmenting of the cRNA for target preparation using the standard
Affymetrix protocol, 15 mg fragmented cRNA were hybridized for
16 h at 45uC to Mouse Genome 430 Version 2.0 Array
(Affymetrix) which includes 45101 probe sets. Following hybrid-
ization, arrays were washed and stained with streptavidin-
phycoerythrin in the Affymetrix Fluidics Station 450 and further
scanned using the Affymetrix GeneChip Scanner 3000 7G. The
image data were analyzed with GCOS 1.4 using Affymetrix
default analysis settings and global scaling as normalization
method. All chips passed quality criteria. Microarray data reported
in the manuscript is described in accordance with MIAME
guidelines and original datasets have been deposited in the
ArrayExpress database for open access (Accession Number E-
TABM-717).
After RMA normalization [31], a parametric ANOVA (F-test)
and ten pair-wise comparisons using the Student t-test (unpaired,
assuming unequal variances) were performed for each time point
independently. The false discovery rate of each test-set was
calculated using the Benjamini Hochberg procedure [58]. Finally,
an ANOVA FDR-value,1023 was used to identify and restrict
the number of differentially expressed probe sets (n = 9456). This
corresponds to a total of 6563 genes.
To cluster these genes in groups with similar expression profiles
along the selected four time points of the monolayer protocol, a cut-
off value of 2 for the fold differences in expression levels between
time points was imposed. Five groups were defined according to the
following criteria (Table S1): I. ‘‘ES cells group’’–Expression level
on day 0 is at least twice higher than expression in all other time
points (days 1, 3 and 8); II. ‘‘PE group’’–Expression level on day 1 is
at least twice higher than expression in all other time points (days 0,
3 and 8); III. ‘‘tNPs group’’–Expression level on day 3 is at least
twice higher than expression in all other time points (days 0, 1 and
8); IV. ‘‘nNPs group’’–Expression level on day 3 (3+ and/or 3++) is
at least twice higher than expression in earlier time points (days 0
and 1), with expression level at day 8 being equal or higher than at
day 3 (day (3++)); V. ‘‘Rosette group’’ - Expression level on day 8 is
at least twice higher than expression in all other time points (days 0,
1 and 3); in addition, expression levels at day 0, 1 and 3 cannot
increase more than twice between them.
Supporting Information
Figure S1 Expression of nanog and Fgf5 at successive time
points of rosette cultures, using RT-PCR
Found at: doi:10.1371/journal.pone.0006286.s001 (0.09 MB
DOC)
Figure S2 Expression of BMP pathway genes obtained by
microarray analysis. Fold changes, relative to day 0, obtained from
Affymetrix profiling for the genes encoding BMP agonists bmp4
and nodal, and BMP inhibitors chordin-like1 (chrld1) and
follistatin (fstl1).
Found at: doi:10.1371/journal.pone.0006286.s002 (0.08 MB TIF)
Figure S3 Expression of Notch pathway genes obtained by
microarray analysis. Fold changes, relative to day 0, obtained from
Affymetrix profiling for the genes encoding Notch receptors
Notch1 and Notch2, Notch ligands Dll1 and Dll3, and Notch
targets hes5 and hes6.
Found at: doi:10.1371/journal.pone.0006286.s003 (1.83 MB TIF)
Table S1 Affymetrix profiling data. A) Worksheet All: list of all
probe sets and respective symbols, title, physical position and
ANOVA:values. B) Worksheet 9456 probe sets: list of 9456 probe
sets (6563 genes), and respective symbols and title, with ANOVA
values lower than 10:3. C) Worksheet ES cells: list of 226 probe sets
(188 genes) that belong to the ES cell expression group. D)
Worksheet PE: list of 80 probe sets (66 genes) that belong to the PE
expression group. E) Worksheet tNPs: list of 75 probe sets (61 genes)
that belong to the tNPs expression group. F) Worksheet nNPs: list of
1171 probe sets (763 genes) that belong to the nNPs expression
group. G) Worksheet Rosettes: list of 919 probe sets (673 genes) that
belong to the Rosette expression group.
Found at: doi:10.1371/journal.pone.0006286.s004 (8.77 MB
XLS)
Table S2 List of antibodies used for the immunostaining
analyses
Found at: doi:10.1371/journal.pone.0006286.s005 (0.04 MB
DOC)
Table S3 List of gene-specific primers used in RT-PCR
Found at: doi:10.1371/journal.pone.0006286.s006 (0.13 MB
DOC)
Movie S1 Interkinetic nuclear movement (INM) in rosette
cultures. Day 6 rosette NPs imaged on an inverted fluorescence
Zeiss Axiovert 200M microscope. The culture was permanently
illuminated and seven focal points were imaged at 2 min intervals,
for up to 16 hours. Data were analysed using ImageJ software, by
choosing the most focused plane, adjusting brightness and
contrast, and after instant time concatenation.
Found at: doi:10.1371/journal.pone.0006286.s007 (9.56 MB ZIP)
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